- Home
- BCRX vs ADEA Comparison
BCRX vs ADEA Comparison
Compare BCRX & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- ADEA
- Stock Information
- Founded
- BCRX 1986
- ADEA 1990
- Country
- BCRX United States
- ADEA United States
- Employees
- BCRX N/A
- ADEA N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- ADEA Computer Software: Prepackaged Software
- Sector
- BCRX Health Care
- ADEA Technology
- Exchange
- BCRX Nasdaq
- ADEA Nasdaq
- Market Cap
- BCRX 1.7B
- ADEA 1.3B
- IPO Year
- BCRX 1994
- ADEA N/A
- Fundamental
- Price
- BCRX $9.92
- ADEA $13.51
- Analyst Decision
- BCRX Buy
- ADEA Strong Buy
- Analyst Count
- BCRX 8
- ADEA 3
- Target Price
- BCRX $16.75
- ADEA $17.33
- AVG Volume (30 Days)
- BCRX 5.7M
- ADEA 499.8K
- Earning Date
- BCRX 05-05-2025
- ADEA 05-05-2025
- Dividend Yield
- BCRX N/A
- ADEA 1.47%
- EPS Growth
- BCRX N/A
- ADEA 89.09
- EPS
- BCRX N/A
- ADEA 0.66
- Revenue
- BCRX $503,485,000.00
- ADEA $380,289,000.00
- Revenue This Year
- BCRX $27.64
- ADEA $10.83
- Revenue Next Year
- BCRX $13.42
- ADEA $3.41
- P/E Ratio
- BCRX N/A
- ADEA $20.58
- Revenue Growth
- BCRX 41.67
- ADEA 7.16
- 52 Week Low
- BCRX $5.06
- ADEA $9.68
- 52 Week High
- BCRX $11.11
- ADEA $17.46
- Technical
- Relative Strength Index (RSI)
- BCRX 65.51
- ADEA 61.53
- Support Level
- BCRX $8.28
- ADEA $12.17
- Resistance Level
- BCRX $11.11
- ADEA $13.32
- Average True Range (ATR)
- BCRX 0.51
- ADEA 0.41
- MACD
- BCRX 0.25
- ADEA 0.21
- Stochastic Oscillator
- BCRX 69.17
- ADEA 92.13
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.